Home > Insider Trading > Filing (0000950170-24-095675)

Filing Details

Accession Number:: 0000950170-24-095675
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-12 20:33:19
Reporting Period:: 2024-08-08

Accepted Time:: 2024-08-12 20:33:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1544227	Tempest Therapeutics Inc.	TPST	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1456589	Versant Ventures Iv, Llc	One Sansome Street Suite 1650 San Francisco CA 94104	No	No	No	No
1456590	Versant Venture Capital Iv, L.p.	One Sansome Street Suite 1650 San Francisco CA 94104	No	No	No	No
1456591	Versant Side Fund Iv, L.p.	One Sansome Street Suite 1650 San Francisco CA 94104	No	No	No	No
1687880	Versant Venture Capital Vi, L.p.	One Sansome Street Suite 1650 San Francisco CA 94104	No	No	No	No
1777652	Versant Ventures Vi Gp-Gp, Llc	One Sansome Street Suite 1650 San Francisco CA 94104	No	No	No	No
1777654	Versant Ventures Vi Gp, L.p.	One Sansome Street Suite 1650 San Francisco CA 94104	No	No	No	No
1832235	Versant Vantage Ii, L.p.	One Sansome Street Suite 1650 San Francisco CA 94104	No	No	No	No
1839789	Versant Vantage Ii Gp-Gp, Llc	One Sansome Street Suite 1650 San Francisco CA 94104	No	No	No	No
1839790	Versant Vantage Ii Gp, L.p.	One Sansome Street Suite 1650 San Francisco CA 94104	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-08-08	400,000	$1.35	597,940	No	4	S	Direct
Common Stock	Disposition	2024-08-12	387,999	$1.10	209,941	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,171,094	Indirect	See Footnote
Common Stock	7,377	Indirect	See Footnote
Common Stock	2,118,644	Indirect	See Footnote

Footnotes

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.35 to $1.375, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
These shares are held of record by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP, L.P. ("VV VI GP") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC ("VV VI GP-GP") is the general partner of VV VI GP and each may be deemed to share voting, investment and dispositive power over the shares held by VVC VI. Each of VV VI GP-GP and VV VI GP disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.10 to $1.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
These shares are held of record by Versant Venture Capital IV, L.P. ("VVC IV"). Versant Ventures IV, LLC ("VV IV") is the general partner of VVC IV and may be deemed to share voting, investment and dispositive power over the shares held by VVC IV. VV IV disclaims beneficial ownership of such shares, except to the extent of its pecuniary interests therein.
These shares are held of record by Versant Side Fund IV, L.P. ("VSF IV"). VV IV is the general partner of VSF IV and may be deemed to share voting, investment and dispositive power over the shares held by VSF IV. VV IV disclaims beneficial ownership of such shares, except to the extent of its pecuniary interests therein.
These shares are held of record by Versant Vantage II, L.P. ("Vantage II"). Versant Vantage II GP, L.P. ("Vantage II GP") is the general partner of Vantage II, and Versant Vantage II GP-GP, LLC ("Vantage II GP-GP") is the general partner of Vantage II GP and each may be deemed to share voting, investment and dispositive power over the shares held by Vantage II. Each of Vantage II GP-GP and Vantage II GP disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.